THOMPSON DAVIS & CO., INC. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 66 filers reported holding TG THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$21,000
+110.0%
1,500
+20.0%
0.06%
+129.2%
Q4 2017$10,000
-72.2%
1,250
-58.8%
0.02%
-62.5%
Q3 2017$36,000
+20.0%
3,0320.0%0.06%
+33.3%
Q2 2017$30,000
-80.5%
3,032
-77.1%
0.05%
-78.2%
Q1 2017$154,000
+185.2%
13,248
+278.5%
0.22%
+238.5%
Q1 2015$54,000
-19.4%
3,500
-17.6%
0.06%
-16.7%
Q4 2014$67,000
+26.4%
4,250
-15.0%
0.08%
+14.7%
Q3 2014$53,000
+2550.0%
5,000
+1900.0%
0.07%
+2166.7%
Q2 2014$2,000
-50.0%
250
-50.0%
0.00%
-57.1%
Q1 2014$4,0000.0%500
-50.0%
0.01%
+16.7%
Q4 2013$4,0001,0000.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders